F. Waechter
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Peroxisome Proliferator-Activated Receptors 12
- Pharmacology 17
- Pharmacogenetics and Drug Metabolism 12
- Drug-Induced Hepatotoxicity and Protection 8
- Co-authors
- P. Bentley (20 shared papers)W. Stäubli (21 shared papers)F. Bieri (17 shared papers)P Maurel (1 shared paper)Lydiane Pichard‐Garcia (1 shared paper)Jean‐Marc Pascussi (1 shared paper)Nicolas Carrère (1 shared paper)J Fabre (1 shared paper)
- Journals
- Toxicology in Vitro (3 papers)Toxicology and Applied Pharmacology (2 papers)Carcinogenesis (2 papers)Experimental Cell Research (2 papers)Toxicological Sciences (2 papers)
- Partner nations
- SwitzerlandGermanyUnited Kingdom
In The Last Decade
F. Waechter
34 papers receiving 794 citations
Peers
Comparison fields: 5 of 94
- Pharmacology 382
- Biochemistry 112
- Cancer Research 121
- Oncology 211
- Hepatology 60
Countries citing papers authored by F. Waechter
This map shows the geographic impact of F. Waechter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Waechter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Waechter more than expected).
Fields of papers citing papers by F. Waechter
This network shows the impact of papers produced by F. Waechter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Waechter. The network helps show where F. Waechter may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Waechter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Induction of CYP2C genes in human hepatocytes in primary culture. | 2001 | 267 |
| 2 | 2007 | 85 | |
| 3 | 1987 | 61 | |
| 4 | 1997 | 48 | |
| 5 | 1982 | 46 | |
| 6 | 1977 | 35 | |
| 7 | 1994 | 31 | |
| 8 | 1979 | 30 | |
| 9 | 2003 | 28 | |
| 10 | 1986 | 21 | |
| 11 | 1988 | 21 | |
| 12 | 1988 | 20 | |
| 13 | 1988 | 16 | |
| 14 | 1999 | 15 | |
| 15 | 1990 | 13 | |
| 16 | 1988 | 12 | |
| 17 | 1988 | 12 | |
| 18 | 1982 | 10 | |
| 19 | 1987 | 10 | |
| 20 | 1990 | 9 |
About F. Waechter
F. Waechter is a scholar working on Molecular Biology, Pharmacology, Oncology, Biochemistry and Cancer Research, having authored 35 papers that have together received 858 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (12 papers), Peroxisome Proliferator-Activated Receptors (12 papers), Drug Transport and Resistance Mechanisms (10 papers), Drug-Induced Hepatotoxicity and Protection (8 papers), Metabolism and Genetic Disorders (5 papers), Carcinogens and Genotoxicity Assessment (5 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Pharmacology (382 citations), Biochemistry (112 citations), Cancer Research (121 citations), Oncology (211 citations) and Hepatology (60 citations). F. Waechter has collaborated with scholars based in Switzerland, Germany and United Kingdom. Frequent co-authors include P. Bentley, W. Stäubli, F. Bieri, P Maurel, Lydiane Pichard‐Garcia, Jean‐Marc Pascussi, Nicolas Carrère, J Fabre, Sabine Gerbal‐Chaloin and Samar F. Muakkassah-Kelly. Their work appears in journals such as Toxicology in Vitro, Toxicology and Applied Pharmacology, Carcinogenesis, Experimental Cell Research and Toxicological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.